Quantum Cyber N.V. (QUCY)
QUCY trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.12
+8.74% on the day
Market cap
$97.7M
Micro cap
Revenue · 2025
$537K
-39.9% on 2024
Net income · 2025
-$16.2M
-3018.3% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | QUCY on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Germany |
| IPO year | 2021 |
| SEC CIK | 0001874252 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | P7 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $537K |
| Net income | -$16.2M |
| Operating income | -$16.1M |
| Net margin | -3018.3% |
| Operating margin | -3005.0% |
| Revenue growth | -39.9% |
| Cash | Not in SEC XBRL data |
| Total assets | $5.3M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 181.9× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2026-10-09 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-03-31 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-14 |
| Latest current report CURRENT REPORT | 8-K | 2026-10-09 |
| Latest proxy DEFINITIVE PROXY STATEMENT | DEF 14A | 2026-06-01 |
Source: SEC EDGAR submissions feed, 203 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PLYX | Polaryx Therapeutics Inc. | $1.94 | -3.48% | $96.7M |
| MIST | Milestone Pharmaceuticals Inc. Common Shares | $0.7658 | -4.93% | $95.3M |
| OKUR | OnKure Therapeutics Inc. | $2.35 | -3.10% | $95.0M |
| IMUX | Immunic Inc. | $6.89 | -13.33% | $94.0M |
| PMVP | PMV Pharmaceuticals Inc. | $1.35 | -4.25% | $101.9M |
| RANI | Rani Therapeutics Holdings Inc. | $0.7332 | -2.36% | $102.2M |
| ANIX | Anixa Biosciences Inc. | $2.67 | -5.99% | $92.8M |
| INO | Inovio Pharmaceuticals Inc. | $0.9982 | -9.66% | $103.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier